3h
Zacks.com on MSNEpsilon Energy (EPSN) Upgraded to Buy: What Does It Mean for the Stock?Epsilon Energy (EPSN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks Research decreased their Q2 2025 earnings per share estimates for shares of CDW in a report released on Wednesday, ...
Equities researchers at Zacks Research lifted their Q2 2026 earnings per share estimates for shares of QUALCOMM in a research ...
2hOpinion
Hosted on MSN3 Real Estate Operations Stocks to Consider Despite Industry WoesThe Zacks Real Estate Operations industry faces disruptions, including geopolitical unrest and macroeconomic challenges, in ...
7h
Zacks.com on MSNBeat the Market the Zacks Way: Verona, Visa, Starbucks in FocusLast Friday, the three most widely followed benchmark indexes closed a mixed week. The Nasdaq Composite and the S&P 500 ...
The New York-based company said it had a loss of $1.90 per share. Earnings, adjusted for non-recurring costs and to account for discontinued operations, were 23 cents per share. The results beat Wall ...
Syndax Pharmaceuticals Inc. (SNDX) ...
DUBLIN (AP) — DUBLIN (AP) — Avadel Pharmaceuticals PLC (AVDL) on Monday reported a loss of $5 million in its fourth quarter. On a per-share basis, the Dublin-based company said it had a loss of 5 ...
SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Monday reported a loss of $59.2 million in its fourth quarter. The San Diego-based company said it had a loss of 9 cents per share. Losses ...
MORRISVILLE, N.Y. (AP) — MORRISVILLE, N.Y. (AP) — TG Therapeutics Inc. (TGTX) on Monday reported fourth-quarter earnings of $23.3 million. On a per-share basis, the Morrisville, New York-based company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results